Scherf-Clavel M - Search Results

1

The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics.

Scherf-Clavel M, Weber H, Deckert J, Erhardt-Lehmann A. Scherf-Clavel M, et al. Expert Opin Drug Metab Toxicol. 2021 Nov;17(11):1249-1260. doi: 10.1080/17425255.2021.1991912. Epub 2021 Oct 15. Expert Opin Drug Metab Toxicol. 2021. PMID: 34643143 Review.

2

Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2.

Scherf-Clavel M, Samanski L, Hommers LG, Deckert J, Menke A, Unterecker S. Scherf-Clavel M, et al. Int Clin Psychopharmacol. 2019 Mar;34(2):93-100. doi: 10.1097/YIC.0000000000000250. Int Clin Psychopharmacol. 2019. PMID: 30557209

3

Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting.

Scherf-Clavel M, Weidner A, Deckert J, Menke A, Unterecker S. Scherf-Clavel M, et al. Pharmacopsychiatry. 2020 Jan;53(1):30-35. doi: 10.1055/a-0869-8053. Epub 2019 Mar 26. Pharmacopsychiatry. 2020. PMID: 30913567

4

Smoking Is Associated With Lower Dose-Corrected Serum Concentrations of Escitalopram.

Scherf-Clavel M, Deckert J, Menke A, Unterecker S. Scherf-Clavel M, et al. J Clin Psychopharmacol. 2019 Sep/Oct;39(5):485-488. doi: 10.1097/JCP.0000000000001080. J Clin Psychopharmacol. 2019. PMID: 31343441

5

Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients.

Scherf-Clavel M, Zebner J, Hommers L, Deckert J, Menke A, Unterecker S. Scherf-Clavel M, et al. Eur J Clin Pharmacol. 2020 Jan;76(1):73-80. doi: 10.1007/s00228-019-02766-2. Epub 2019 Oct 23. Eur J Clin Pharmacol. 2020. PMID: 31641787

6

Extent of cortisol suppression at baseline predicts improvement in HPA axis function during antidepressant treatment.

Scherf-Clavel M, Wurst C, Nitschke F, Stonawski S, Burschka C, Friess L, Unterecker S, Hommers L, Deckert J, Domschke K, Menke A. Scherf-Clavel M, et al. Psychoneuroendocrinology. 2020 Apr;114:104590. doi: 10.1016/j.psyneuen.2020.104590. Epub 2020 Jan 26. Psychoneuroendocrinology. 2020. PMID: 32006918

7

Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs.

Scherf-Clavel M, Treiber S, Deckert J, Unterecker S, Hommers L. Scherf-Clavel M, et al. Pharmacopsychiatry. 2020 Sep;53(5):229-234. doi: 10.1055/a-1157-9433. Epub 2020 Apr 27. Pharmacopsychiatry. 2020. PMID: 32340061

8

Therapeutic Drug Monitoring of Antidepressants for the Treatment of Chronic Musculoskeletal Pain With and Without Depression.

Scherf-Clavel M, Breisinger S, Fischer M, Deckert J, Unterecker S, Rittner HL. Scherf-Clavel M, et al. Ther Drug Monit. 2020 Dec;42(6):893-901. doi: 10.1097/FTD.0000000000000783. Ther Drug Monit. 2020. PMID: 32569061

9

Higher venlafaxine serum concentrations necessary for clinical improvement? Time to re-evaluate the therapeutic reference range of venlafaxine.

Scherf-Clavel M, Hommers L, Wurst C, Stonawski S, Deckert J, Domschke K, Unterecker S, Menke A. Scherf-Clavel M, et al. J Psychopharmacol. 2020 Oct;34(10):1105-1111. doi: 10.1177/0269881120936509. Epub 2020 Jul 16. J Psychopharmacol. 2020. PMID: 32669065

10

Impact of Body Mass Index on Serum Concentrations of Antidepressants and Antipsychotics.

Warrings B, Samanski L, Deckert J, Unterecker S, Scherf-Clavel M. Warrings B, et al. Ther Drug Monit. 2021 Apr 1;43(2):286-291. doi: 10.1097/FTD.0000000000000812. Ther Drug Monit. 2021. PMID: 32910098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters